Tsukasaki Kunihiro, Lohr Dirk, Sugahara Kazuyuki, Kamihira Shimeru, Tomonaga Masao, Bartram Claus R, Jauch Anna
Department of Hematology, Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Science, Nagasaki, Japan.
Leuk Lymphoma. 2006 Feb;47(2):261-6. doi: 10.1080/10428190500287828.
B-cell chronic lymphocytic leukemia (B-CLL) is the most common leukemia in Westerners. By contrast, B-CLL is rare in Asians, including Japanese. We applied comparative genomic hybridization (CGH) to screen 26 newly diagnosed Japanese B-CLL patients for genomic aberrations. Chromosomal imbalances were detected in 12 of the 26 cases (46%). The most frequent changes observed were gains of chromosomes 3q in five cases (19%) and 17q in three cases (12%). Other recurrent imbalances included gains of chromosomes 8q, 18q and losses of chromosomes 13q and 17p. Samples obtained at different sites disclosed identical CGH findings in all of the three cases examined. Genomic imbalances as detected by CGH were associated with disease progression and shorter survival. Two patients, with chromosomal imbalances, including gains of both 3q and 18q, developed large cell transformation of the disease within 4 years. In conclusion, CGH abnormality was associated with poor prognosis in Japanese B-CLL, and features of Japanese B-CLL, compared to chromosomal abnormalities of Western B-CLL in the literature, include a lower incidence of any abnormality in particular regarding gain of 12q, with the exception of a higher incidence of gains at 3q.
B 细胞慢性淋巴细胞白血病(B-CLL)是西方人中最常见的白血病。相比之下,B-CLL 在包括日本人在内的亚洲人中较为罕见。我们应用比较基因组杂交(CGH)技术对 26 例新诊断的日本 B-CLL 患者进行基因组畸变筛查。26 例中有 12 例(46%)检测到染色体失衡。观察到的最常见变化是 5 例(19%)出现 3q 染色体增益,3 例(12%)出现 17q 染色体增益。其他反复出现的失衡包括 8q、18q 染色体增益以及 13q、17p 染色体缺失。在所有检测的 3 例中,不同部位获取的样本显示出相同的 CGH 结果。CGH 检测到的基因组失衡与疾病进展和较短生存期相关。两名染色体失衡(包括 3q 和 18q 均增益)的患者在 4 年内疾病发生了大细胞转化。总之,CGH 异常与日本 B-CLL 的不良预后相关,与文献中西方 B-CLL 的染色体异常相比,日本 B-CLL 的特征包括任何异常的发生率较低,特别是 12q 增益,不过 3q 增益的发生率较高。